1. Home
  2. /
  3. Phase II-IV Clinical Trial...

Phase II-IV Clinical Trials Management

Vast Therapeutic Expertise, Global Reach, and Seamless Execution

At Lambda Therapeutic Research, a trusted CRO, we specialize in facilitating Late Phase (Phase II-IV Clinical Trial Management)​ for investigational new drugs (INDs), biologics, and medical devices. With a foundation of strong scientific expertise, we provide a solid foundation to manage complex, multi-centric clinical programs across diverse therapeutic areas. Our comprehensive services cover the entire clinical trial lifecycle, from study feasibility and pre-site qualification to patient recruitment, site management, and rigorous study monitoring. Whether through Central Monitoring, Remote Monitoring, or on-site monitoring, we ensure seamless execution and optimal results for your clinical development programs

0 +
Late Phase Studies
0 +
Patients
0 +
Sites

Lambda & Novum has enrolled 85000+ patients in various therapeutic categories and conducted over 275+ multicentric trials across different geographies with data submitted to all leading agencies including US FDA, EMEA, DCGI, ANVISA. 

Therapeutic Expertise:

Lambda specializes in assisting small and mid-sized biotech Companies focused on groundbreaking science, particularly in intricate and challenging disease areas. Our robust investigator network and expertise in Late Phase Clinical Trials for therapeutic areas such as oncology, dermatology, CNS, Psychiatry, musculoskeletal, rheumatology, ophthalmology, and more, make us well-positioned to address the challenges of late-stage drug development. With our extensive experience and proven expertise in these therapeutic areas, we help your team bring new therapies to patients.

 
See All Areas of Expertise

No Data Found

Patient-Based PK Studies

With a proven track record, we accelerate patient-based PK studies across therapeutic areas, overcoming challenges with precision and innovation, backed by experience in over 50 studies across diverse indications.

  • Acute Myeloid Leukaemia in Remission Phase
  • Advanced Breast Cancer
  • Advanced Ovarian Cancer or Metastatic Breast Cancer
  • Advanced Solid Malignancies
  • Breast Cancer
  • Chronic Myeloid Leukemia / Philadelphia chromosome positive Chronic Myeloid Leukaemia
  • Chronic Refractory Immune (Idiopathic) Thrombocytopenic Purpura
  • Glioblastoma Multiforme or Anaplastic Astrocytoma / Malignant Gliomas
  • HER2-Positive Hormone Receptor-Negative Locally Advanced or Early Breast Cancer
  • Iron Deficiency Anaemia
  • Knee Osteoarthritis
  • Metastatic Breast Cancer
  • Metastatic Breast Cancer and Colorectal Cancer
  • Moderate to Severe Atopic Dermatitis
  • Ovarian Cancer
  • Pancreatic or Ovarian Cancer
  • Rheumatoid Arthritis / Psoriasis
  • Schizophrenia
  • Solid Tumour

Experience the Lambda Advantage

Lambda’s Phase II-IV Clinical Trial Management services offer a blend of experience, global reach, and disciplined execution. We empower your clinical trials with tailored solutions, propelling your product towards successful commercialization while ensuring utmost safety and efficiency. Trust Lambda to manage your trials with expertise and precision, meeting your unique objectives at every stage of development.

Experts from various fields such as medicine, pharmacy, biotechnology, and life sciences, ensuring a comprehensive approach to clinical trial management.

Streamlining the entire process from inception to commercialization.

Extensive experience in managing multi-centric clinical trials spanning diverse therapeutic areas, ensuring a global perspective in study execution.

Leveraging our extensive global site alliance network, we ensure efficient trial conduct and data collection across various regions.

Strong expertise in New Drug Delivery Systems (NDDS) and biosimilars, adding a strategic edge to your clinical development.

Proven track record in handling complex molecules across a wide range of therapeutic areas, bringing valuable insights to your trials.

We utilize a sophisticated and fully customizable Clinical Trial Management System (CTMS), seamlessly integrating every facet of the trial process. This technology allows for real-time data access, efficient communication, and informed decision-making.

Contact Us Today to Start Your Phase II-IV Clinical Trial Management

Ready to take your Phase II-IV clinical trials to the next level? Partner with Lambda and Novum to benefit from our vast therapeutic expertise, global reach, and tailored solutions. Get in touch now to discuss how we can support your clinical development programs with precision and excellence.

Let's Unveil New Therapies Together

Connect with our experts to leverage our proven track record of clinical research excellence.

Contact Now